BATS BZX Real-Time Price
As of 12:55pm ET
| -0.62 / -8.64%|
The 8 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 11.50, with a high estimate of 40.00 and a low estimate of 8.00. The median estimate represents a +75.30% increase from the last price of 6.56.
The current consensus among 9 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.